The estimated Net Worth of James M Denny is at least $25.5 Million dollars as of 28 November 2012. James Denny owns over 64,000 units of Gilead Sciences stock worth over $24,375,729 and over the last 21 years James sold GILD stock worth over $1,110,348.
James has made over 15 trades of the Gilead Sciences stock since 2003, according to the Form 4 filled with the SEC. Most recently James exercised 64,000 units of GILD stock worth $1,496,320 on 28 November 2012.
The largest trade James's ever made was exercising 64,000 units of Gilead Sciences stock on 28 November 2012 worth over $1,496,320. On average, James trades about 9,939 units every 79 days since 2003. As of 28 November 2012 James still owns at least 301,158 units of Gilead Sciences stock.
You can see the complete history of James Denny stock trades at the bottom of the page.
James's mailing address filed with the SEC is 333 LAKESIDE DRIVE, , FOSTER CITY, CA, 94404.
Over the last 22 years, insiders at Gilead Sciences have traded over $221,090,692 worth of Gilead Sciences stock and bought 30,121 units worth $1,879,767 . The most active insiders traders include John C Martin, Norbert W Bischofberger, and John F Milligan. On average, Gilead Sciences executives and independent directors trade stock every 9 days with the average trade being worth of $3,341,365. The most recent stock trade was executed by Deborah H Telman on 10 September 2024, trading 639 units of GILD stock currently worth $51,721.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Gilead Sciences executives and other stock owners filed with the SEC include: